Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
about
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis BEnhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.An evaluation of the emerging vaccines against influenza in children.Improved data visualization techniques for analyzing macromolecule structural changes.Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
P2860
Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Formulation development of a p ...... mbinant hemagglutinin antigen.
@en
Formulation development of a p ...... mbinant hemagglutinin antigen.
@nl
type
label
Formulation development of a p ...... mbinant hemagglutinin antigen.
@en
Formulation development of a p ...... mbinant hemagglutinin antigen.
@nl
prefLabel
Formulation development of a p ...... mbinant hemagglutinin antigen.
@en
Formulation development of a p ...... mbinant hemagglutinin antigen.
@nl
P2093
P2860
P356
P1476
Formulation development of a p ...... mbinant hemagglutinin antigen.
@en
P2093
C Russell Middaugh
Jessica A Chichester
Mangala Roshan Liyanage
R Mark Jones
Sangeeta B Joshi
Vidadi Yusibov
Vidyashankara Iyer
Yoko Shoji
P2860
P304
P356
10.4161/HV.19106
P577
2012-02-28T00:00:00Z